MedPath

Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontinence

Not Applicable
Terminated
Conditions
Fecal Incontinence
Interventions
Device: Posterior tibial nerve stimulation (PTNS)
Device: Posterior tibial nerve stimulation
Registration Number
NCT01274585
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The primary objective of this study is to determine whether Percutaneous Tibial Nerve Stimulation (PTNS), a minimally invasive, simple, cost effective, and outpatient treatment of patients with urinary incontinence, can also be used to treat fecal incontinence. Specifically, the primary endpoint of this study is to determine, in a randomized controlled patient blinded study, whether PTNS decrease the episodes of fecal incontinence by 50% in the patients treated with PTNS when compared to placebo as documented by a 2 week patient bowel diary after treatment.

The investigators secondary endpoints will consist of measurements of the impact of PTNS on the severity of incontinence (defined as a decrease in the mean Fecal Incontinence Severity Index (FISI) score ), as well as on the patient quality of life factors related to fecal incontinence (defined as a decrease in the mean Fecal Incontinence Quality of Life (FIQoL) scale).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • 18 years or older
  • Able to provide informed consent
  • Has severe fecal incontinence (defined as weekly episodes of incontinence of mucus, liquid or solid stool)
  • Available to present for weekly treatments
  • Available for follow-up at 3, 6, and 12 months
Exclusion Criteria
  1. Severe cardiopulmonary disease
  2. Lesion of the Tibial Nerve
  3. Use of a cardiac pacemaker or implantable defibrillator
  4. History of inflammatory bowel disease
  5. Active anal fissure, fistula, or abscess
  6. Active rectal bleeding which has not been evaluated with appropriate testing, such as colonoscopy
  7. Has a sphincter injury that needs sphincteroplasty
  8. Wants to pursue aggressive surgical therapy with a colostomy or an artificial bowel sphincter
  9. Severe distal venous insufficiency
  10. Uncontrolled diabetes with peripheral nerve involvement
  11. Immunosuppression
  12. Pregnant or planning on becoming pregnant during treatment
  13. Patients prone to bleeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
stimulation/treatmentPosterior tibial nerve stimulation (PTNS)-
No active treatmentPosterior tibial nerve stimulation-
Primary Outcome Measures
NameTimeMethod
Frequency of Fecal IncontinenceDiary kept for 14 days following treatment

Patient kept 2 week bowel diary after completion of treatment. Bowel diary were collected to assess frequency of fecal incontinence in the two week span.

Secondary Outcome Measures
NameTimeMethod
Change in Fecal Incontinence Severity Index (FISI) Score12 weeks

Fecal Incontinence Severity Index (FISI) is a tool used to stratify severity of fecal incontinence in the subjects. The range of score is from 0 to 61 where the higher score correlates with more severe symptoms of incontinence.

Change in Fecal Incontinence Quality of Life (FIQoL) Score12 weeks

The Fecal incontinence Quality of Life (FIQoL) score evaluates how fecal incontinence impacts the subjects quality of life. The scale ranges from 37 to 159 where the higher the score, the better the quality of life associated with symptoms.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath